Press Releases
BrightFocus proudly supports over 200 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation has received a $3.2 million grant from an anonymous foundation to support 12 new Alzheimer’s Disease Research grants over the next three years as part of its Innovative Seed Funding Program.
Boosting research investment into the health and wellbeing of adults with Down syndrome would improve their quality-of-life outcomes, reduce caregiving costs, and extend the lifespan of adults with Down syndrome by five years, according to a RAND report commissioned by LuMind IDSC Foundation, the Alliance for Aging Research, BrightFocus Foundation, and the National Down Syndrome Society.
BrightFocus Foundation’s 2024 annual report highlights groundbreaking research and public awareness efforts over the last year to defeat Alzheimer’s disease, macular degeneration, and glaucoma.
In response to overwhelming interest in its first six episodes, four additional episodes of Zoom In on Dementia & Alzheimer’s will walk participants through specific Alzheimer’s clinical trials and research studies.
BrightFocus Foundation hosted its inaugural Concert for Cures on Wednesday, June 26, at City Winery in Nashville.
Global brain and vision research nonprofit BrightFocus Foundation has appointed Dr. Adam Myers as a new member of its board of directors.
Global brain and vision research nonprofit BrightFocus Foundation and the Helen Keller Foundation for Research and Education have named ophthalmologist José Cunha-Vaz, MD, PhD, the recipient of the 2024 Helen Keller Prize for Vision Research in recognition of his immense contributions to the field.
On May 6, BrightFocus Foundation recognized five vision scientists for their research focused on preventing, treating, and curing macular degeneration and glaucoma during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more than 335 million people worldwide.
